References
- Simone B, De Stefano V, Leoncini E, et al. Risk of venous thromboembolism associated with single and combined effects of factor V Leiden, prothrombin 20210A and methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol. 2013;28(8):621–647. doi:10.1007/s10654-013-9825-8
- Favaloro EJ. Genetic testing for thrombophilia-related genes: observations of testing patterns for factor V Leiden (G1691A) and prothrombin gene “Mutation” (G20210A). Semin Thromb Hemost. 2019;45(7):730–742. doi:10.1055/s-0039-1694772
- Campello E, Spiezia L, Dalla Valle F, Tormene D, Simioni P. Factor V Leiden paradox and the occurrence of distal vein thrombosis in a large cohort of thrombotic patients. Thromb Res. 2017;156:20–22. doi:10.1016/j.thromres.2017.05.025
- Nielsen VG, Hafner DT, Steinbrenner EB. Tobacco smoke-induced hypercoagulation in human plasma: role of carbon monoxide. Blood Coagul Fibrinolysis. 2013;24:405–410. doi:10.1097/MBC.0b013e32835d5458
- Chan P, Tomlinsoin B, Tsai CW, Pan WH, Lee YS. Thrombophilia in patients with hypercholesterolemia. Metabolism. 1996;45:966–969.
- Ziakas PD, Poulou LS, Pavlou M, Zintzaras E. Thrombophilia and venous thromboembolism in pregnancy: a meta-analysis of genetic risk. Eur J Obstet Gynecol Reprod Biol. 2015;191:106–111. doi:10.1016/j.ejogrb.2015.06.005
- Trenor CC, Chung RJ, Michleson AD, et al. Hormonal contraception and thrombotic risk: a multidisciplinary approach. Pediatrics. 2011;127(2):347–357. doi:10.1542/peds.2010-2221
- Momot AP, Nikolaeva MG, Yasafova NN, Zainulina MS, Momot KA, Taranenko IA. Clinical and laboratory manifestations of the prothrombin gene mutation in women of reproductive age. J Blood Med. 2019;10:255–263. doi:10.2147/JBM.S212759